ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada

Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada.

Adrian Wagg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.